2 days What’s next for hot biotech stock Viking Therapeutics? Here’s how the company can scale up. MarketWatch X
3 days Big Pharma, Beaten Down Under Biden, Hopes for New Chapter Under Trump The Wall Street Journal X
6 days Here’s How Donald Trump Could Shake Up Health Care — And Biotech Stocks Investor's Business Daily X
1 week Biotech Stock Roundup: MRNA, NTLA Down on Updates, SAGE Up on Biogen’s Offer & Other Updates Zacks X
1 week BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps. Investor's Business Daily X
2 weeks Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy The Next Web X
2 weeks Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More Zacks X
2 weeks Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts. Investor's Business Daily X
2 weeks Sana Biotech’s islet cell therapy shows promise in diabetes; shares surge 150% postmarket Investing.com X
2 weeks Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5) Seeking Alpha X
3 weeks A successful VC predicts what the next 10 years in the venture capital industry will look like Business Insider X
3 weeks Neumora Therapeutics’ stock craters after trial of major depressive disorder fails to meet main goals MarketWatch X
4 weeks How Tarsus Pharmaceuticals’ Unique Inspiration Is Driving A Triple-Digit Run Investor's Business Daily X
4 weeks 2025 Analyst Outlook: Edmund Ingham On Biotech Big And Small, And A Key Milestone Seeking Alpha X
1 month Investors optimistic about continued biotech and medtech IPO resurgence in 2025 Yahoo Finance X
1 month Top-Notch Biotech Mesoblast Skyrockets On Immune Condition Approval Investor's Business Daily X
1 month Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains Zacks X
1 month Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030 Yahoo Finance X
1 month RFK Jr. could prove a surprise boon for stem-cell stocks with pivotal year ahead MarketWatch X
1 month Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More Zacks X
1 month Investors Slaughter Q32 Bio On A ‘Messy’ Update In Eczema, Alopecia Treatment Investor's Business Daily X
1 month Candel Skyrockets 68% On A Potential First-In-20-Years Cancer Drug Investor's Business Daily X
1 month NewAmsterdam Pharma Soars 41% On A Surprise Benefit From Cholesterol Drug Investor's Business Daily X
1 month CervoMed’s stock craters 77% after failed trial of treatment for rare brain disease MarketWatch X
2 months Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. Investor's Business Daily X